| IV-17 Yumi Cleary Physiologically-based pharmacokinetic modelling of basmisanil to evaluate CYP3A mediated victim and perpetrator drug-drug interaction propensity Thursday 15:00-16:30 |
| IV-17 Yumi Cleary Physiologically-based pharmacokinetic modelling of basmisanil to evaluate CYP3A mediated victim and perpetrator drug-drug interaction propensity Thursday 15:00-16:30 |